United States · FDA National Drug Code directory
XGEVA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55513-730_3ce47aaf-105d-4615-9320-1f378a9d8d84
- Product NDC
- 55513-730
- Form
- INJECTION
- Composition / generic term
- denosumab
- Labeler
- Amgen, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20101118
- Source listing expiry
- 20271231
Source-listed ingredients
- DENOSUMAB — 120 mg/1.7mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) / 1.7 mL in 1 VIAL, SINGLE-USE · 55513-730-01
- 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-21) / 1.7 mL in 1 VIAL, SINGLE-USE · 55513-730-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →